AstraZeneca on Track for Reaching $80 Bln Sales Target, CFO Says
Share
AstraZeneca Chief Financial Officer Aradhana Sarin says the company is "very much on track" to reach its $80 billion sales target by 2030. "From a pharma standpoint, we are probably one of the most diversified from a product and pipeline, as well as probably the most diversified geographically," Sarin says. She speaks on Bloomberg Television as the company reported higher-than-expected profit, buoyed by blockbuster cancer medicines.
More from Australia
Capital battles heat up as takeover offers challenge listed housing operators
The equities fueling the next infrastructure supercycle
Crypto networks collide with sanctions in a fight for financial access
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027
Celsius Resources updates market on US$5M dispute